510(k) Flow Chart Explains U.S. FDA Review Process
Concerns about the future of the U.S. Food and Drug Administration’s (FDA) 510(k) process appear to have been put to rest with the recent issuance of a draft guidance on evaluating substantial equivalence in 510(k)s.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.